2020-07-28 GP (HK) Enters into a Capital Subscription and Acquisition Agreement, Acquires the Third-Generation Stent Retriever Contributing to Achieve the Strategic Plan of “Treating the Heart and Brain with the Same Therapeutic Method”

2020-06-01 GP (HK) Enters into an Investment Agreement with eTheRNA Introducing the mRNA Vaccine Platform To Enrich Product Pipeline and Extend the Reach in Multiple Therapeutic Areas

2020-05-19 GP (HK) Announces 2019 Annual Report Three Core Competitiveness Strengthens its Path to an International Pharm Company

2020-05-08 GP (HK)’s World-wide Innovative Drug STC3141 Got Approval for Phase II Clinical Research on COVID-19 ARDS and Phase IB Clinical Research on Sepsis, High-quality Product Contributes to Global Epidemic Prevention & Control

2020-04-28 GP (HK) Obtains Medical Device Registration Certificate for the First Drug Coated Balloon Specified for Vascular Access for Hemodialysis in the PRC Market

2020-04-14 Grandpharma Introduces the Global Innovative Drug CBT001 in Ophthalmology Field

2020-04-01 GP (HK) Announces 2019 Annual Results

2020-04-01 COVID-19 Prevention and Control Should Ensure

2020-03-30 Grandpharma Wins Best Ir Hong Kong Company Award

2019-12-05 Griffith and Grandpharma sign landmark deal to develop new drug for parainfluenza virus

2019-06-27 Sirtex Medical reaches milestone 100,000th patient dose delivery of SIR-Spheres® Y-90 resin microspheres